Spheroid-based |
Incorporation of collagen/fibrin hydrogels with MSC/HUVEC spheroids |
Enhanced functionality due to the presence of vascularized networks |
[79] |
Culturing SVF-derived cells in EGM2 using forced floating cell culture method |
Presence of dense and highly organized vascular networks, showcasing morphology similar to that of in vivo vasculature |
[81] |
Co-culturing β cells and ECs using magnetic levitation method |
Heterogeneous distribution of cells, distinguishable CD31 expression, and significant stimulation of basal insulin secretion |
[83] |
Seeding HUVECs, hTMSCs, and ADSCs on a micro-patterned hydrogel surface |
Six-fold increase in CD31 expression for harvested spheroids, allowing them to be used as building blocks for constructing complex 3D microtissues |
[84] |
Incorporating 2D cell monolayer of HUVECs with MG-63 spheroids cultured using hanging drop technique |
Enhanced vascularization from increased VEGF expression |
[85] |
Bioprinting-based |
Seeding MCTSs on bioprinted blood vessel layer using a cell-ladened bioink with HUVECs and LFs in GAF hydrogel |
Significant vascularization and accurate anti-cancer drug treatment results; coherent with results in mice cells |
[86] |
Fusing stem cells and organoids through bioprinting constraints, making them self-organizing building blocks |
Ability to showcase multicellular self-organization and control over printing parameters to replicate native ECM |
[87] |
Dual extrusion head bioprinter, utilizing two bioinks: parenchymal bioink 1 and non-parenchymal bioink 2 |
Exhibited similar physiological and metabolic properties, as well as highlighted the need of using primary cell lines for accurate modelling |
[88] |
Preset extrusion bioprinting, where preset cartridge mimics the structure of a human hepatic lobule |
Increased drug resistance and higher levels of albumin, MPR2, and CD31 relative to non-engineered models |
[89] |
Dynamic flow-based 3D vascularized tumor model consisting of central vasculature and perfusion chamber |
Significant angiogenesis and successful perfusion for a physiologically relevant drug and immunotherapy screening platform |
[90] |
Microfluidic-device-based |
Multicellular spheroids using ECs and LFs seeded into fibrin–collagen hydrogel embedded within a microfluidic device |
Showcased increased cellular migration, allowing accurate modeling and the studying of cancer metastasis to be performed |
[91] |
Kidney organoid on-a-chip system involving a PDMS chip and organoids cultured in microwells under dynamic flow conditions |
Cultured organoids showed increased vascularization and maturation |
[92] |
Retina on-a-chip system involving a layered microfluidic chip and perfusion through connections via microchannels |
First in vitro system to replicate key in vivo physiological features by showcasing interactions between photoreceptors and retinal pigment epithelium |
[93] |
Bi-compartmental, monolithic heart-on-a-chip device capable of 3D carbon electrodes integration for electrical pacing |
Accurate recapitulation of native cardiac tissue via electromechanical stimulations, endothelial monolayer, and selective perfusion |
[94] |
Mimicking native ECM utilizing a decellularized liver ECM hydrogel in a microfluidic device |
Increased drug sensitivity, and mature and functional hepatic state; high-throughput drug screening platform, and capable of multiorgan model studies |
[95] |